Butcher Arthur C's Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 4, 2025
- Accession no.
- 0001225208-25-001195
- Filed
- Feb 4, 2025
- Trade date
- Feb 3, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.76M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Butcher Arthur CCIK 0001678249 | Officer (EVP& Grp Pres, MedSurg & APAC) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Common Stock | MOption exerciseAcquired | +6,952 | $27.09 | +$188,329.68 | 12,454 | Direct | |
| Feb 3, 2025 | Common Stock | MOption exerciseAcquired | +6,176 | $24.55 | +$151,620.8 | 18,630 | Direct | |
| Feb 3, 2025 | Common Stock | MOption exerciseAcquired | +3,176 | $22.71 | +$72,126.96 | 21,806 | Direct | |
| Feb 3, 2025 | Common Stock | MOption exerciseAcquired | +1,009 | $17.26 | +$17,415.34 | 22,815 | Direct | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −8,508 | $101.45F2 | −$863,136.6 | 14,307 | Direct | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −8,805 | $102.14F3 | −$899,342.7 | 5,502 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Common Stock | MOption exerciseDisposed | −6,952 | $0.00 | $0 | 20,856 | Direct | |
| Feb 3, 2025 | Common Stock | MOption exerciseDisposed | −1,009 | $0.00 | $0 | 3,027 | Direct | |
| Feb 3, 2025 | Common Stock | MOption exerciseDisposed | −6,176 | $0.00 | $0 | 18,527 | Direct | |
| Feb 3, 2025 | Common Stock | MOption exerciseDisposed | −3,176 | $0.00 | $0 | 9,530 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.895 to $101.86, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $101.93 to $102.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.